Latest news

Cynata Therapeutics ASX CYP phase two trial bone marrow graft vs host disease

Phase 2 bone marrow transplant drug trial on the horizon for Cynata Therapeutics

Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) may advance to a phase 2 clinical trial of a new stem cell drug if results of an initial two-stage trial continue to...
Kalium Lakes ASX KLL offtake sulphate of potash KS

Kalium Lakes collars agreement with K+S for 100% of sulphate of potash offtake

Kalium Lakes (ASX: KLL) is closer to becoming what it claims is Australia’s first sulphate of potash producer after it announced it has attained an offtake agreement with one of the world’s largest sulphate...
Rhinomed ASX RNO medical cannabis marijuana Columbia Care

Rhinomed partners with largest medical cannabis operator in the US

Australian medical technology company Rhinomed (ASX: RNO) has signed a deal that could see its nasal technology receive accelerated multilateral development and greater adoption in key markets around the world. Rhinomed has signed a non-binding...
EVE Investments ASX acquires Jenbrook Australian organic tea tree oil

EVE Investments acquires leading Australian organic tea tree oil producer

EVE Investments (ASX: EVE) emerged out its trading halt earlier today to announce that it intends to acquire the entirety of organic tea tree oil producer Jenbrook for around A$2.9 million from its founder...
Rhythm Biosciences RHY colorectal cancer test ColoSTAT cloning reagent

Rhythm Biosciences advances development of novel colorectal cancer test

Medical diagnostics technology company Rhythm Biosciences (ASX: RHY) is continuing the development of its novel test for colorectal cancer, named ColoSTAT. As part of this work, the company says it has achieved a major technical...
King River Copper ASX KRC Mt Remarkable gold Speewah vanadium study

Mt Remarkable offers up high-grade gold for King River Copper, while Speewah vanadium study continues

King River Copper (ASX: KRC) has struck up to 82.7 grams per tonne gold from ongoing drilling at its Mt Remarkable project, while reporting its vanadium concept study into unlocking the vanadium potential at...
Queensland Bauxite ASX QBL medical cannabis limited Medcan

Queensland Bauxite consolidates position in medical cannabis with double acquisition spree

After several months of tiptoeing in and around the medical cannabis market (and almost two months spent in a trading halt), Queensland Bauxite (ASX: QBL) has plunged in two feet first by carrying out...
Legend Mining ASX LEG Rockford nickel-copper

Legend Mining uncovers third mineralised body at Rockford nickel-copper project

Aircore drilling at Legend Mining’s (ASX: LEG) Rockford project in Western Australia has returned nickel-copper sulphide mineralisation, confirming a third mineralised intrusive body. The company requested a trading halt this morning before announcing the assay...
Botanix Pharmaceuticals ASX BOT funded complete atopic dermatitis trial

Botanix Pharmaceuticals fully funded to complete phase 2 atopic dermatitis trial

Medical dermatology company Botanix Pharmaceuticals (ASX: BOT) has raised A$8 million through an oversubscribed placement to professional, institutional and sophisticated investors across Australia and Asia. The raising comes at a critical juncture in the company’s development as...
Bass Metals ASX BSM lithium spodumene bearing pegmatite Millies Reward

Bass Metals earmarks lithium targets at Millie’s Reward

Bass Metals (ASX: BSM) continues to report steady progress during its phase 1 field assessment program across eight exploration targets within the highly-prospective Millie’s Reward lithium project in central Madagascar. Four of those exploration targets...